We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$331M
Cap. Flow %
-8.17%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARLO icon
901
Arlo Technologies
ARLO
$1.73B
$463K 0.01%
41,394
-17,405
-30% -$202K
PTC icon
902
PTC
PTC
$15.1B
$459K 0.01%
+2,499
New +$474K
STNG icon
903
Scorpio Tankers
STNG
$3.71B
$457K 0.01%
+9,195
New +$525K
PSQH.WS icon
904
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.34M
$456K 0.01%
+100,440
New +$38.7K
APD icon
905
Air Products & Chemicals
APD
$65.7B
$455K 0.01%
+1,569
New +$493K
LEG icon
906
Leggett & Platt
LEG
$1.4B
$455K 0.01%
+47,373
New +$567K
TXN icon
907
Texas Instruments
TXN
$254B
$452K 0.01%
2,412
-8,067
-77% -$1.61M
GALT icon
908
CALL
Galectin Therapeutics
GALT
$203M
$449K 0.01%
348,200
+202,000
+138% +$484K
GALT icon
909
PUT
Galectin Therapeutics
GALT
$203M
$449K 0.01%
348,200
+202,000
+138% +$484K
TRMD icon
910
TORM
TRMD
$2.93B
$448K 0.01%
+23,331
New +$569K
DECA
911
DELISTED
Denali Capital Acquisition Corp. Class A Ordinary Shares
DECA
$445K 0.01%
37,499
-1
-0% -$12
DGX icon
912
Quest Diagnostics
DGX
$26B
$444K 0.01%
+2,940
New +$457K
FWRD icon
913
Forward Air
FWRD
$487M
$443K 0.01%
+13,728
New +$479K
BR icon
914
Broadridge
BR
$18.6B
$438K 0.01%
1,938
-43
-2% -$9.63K
CARR icon
915
Carrier Global
CARR
$53.9B
$438K 0.01%
6,418
+647
+11% +$48.8K
CMG icon
916
Chipotle Mexican Grill
CMG
$43.7B
$438K 0.01%
7,261
-12,319
-63% -$742K
CWBC
917
Community West Bancshares
CWBC
$699M
$437K 0.01%
+22,562
New +$449K
AXTA icon
918
Axalta
AXTA
$8.15B
$436K 0.01%
+12,751
New +$480K
ANRO icon
919
Alto Neuroscience
ANRO
$1.09B
$436K 0.01%
+103,100
New +$643K
INBX icon
920
Inhibrx
INBX
$1.23B
$435K 0.01%
28,230
-1
-0% -$15
PVH icon
921
PVH
PVH
$4.01B
$433K 0.01%
+4,090
New +$419K
AMT icon
922
American Tower
AMT
$78.3B
$432K 0.01%
2,353
-20,003
-89% -$4.14M
PRCH icon
923
Porch Group
PRCH
$1.79B
$430K 0.01%
+87,415
New +$281K
SW
924
Smurfit Westrock
SW
$25.4B
$428K 0.01%
7,951
-3,281
-29% -$167K
IMUX icon
925
Immunic
IMUX
$191M
$425K 0.01%
42,531
+179
+0.4% +$2.25K

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $331M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.